Acute Respiratory Distress Syndrome (ARDS) Clinical Trials
2 recruiting trials for Acute Respiratory Distress Syndrome (ARDS). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Acute Respiratory Distress Syndrome (ARDS) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by XiaoJing Zou,MD (1), Centre Hospitalier de la côte Basque (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Transpulmonary Pressure-Guided PEEP Titration in IAH and ARDS Patients (other, 1 trial), followed by EIT-Guided PEEP Titration in IAH and ARDS Patients.
Track Acute Respiratory Distress Syndrome (ARDS) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography-guided PEEP Titration Methods in...
This study aims to adopt a randomized crossover design to compare the effects of end-expiratory transpulmonary pressure-guided PEEP titration and EIT-guided PEEP titration on...
Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress...
Mechanical ventilation in COPD requires a good interaction Patient-Ventilator without asynchronies in order to reduce mortality. Dynamic hyperinflation with PEEPi is responsible...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Acute Respiratory Distress Syndrome (ARDS), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Acute Respiratory Distress Syndrome (ARDS), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Acute Respiratory Distress Syndrome (ARDS), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.